Your browser doesn't support javascript.
loading
Pharmacokinetics and exposure-efficacy relationships of omalizumab in patients with nasal polyps.
Zhu, Rui; Owen, Ryan; Wilkins, Justin; Schoemaker, Rik; Tian, Xianbin; Gautier, Aurelie; She, Gaohong; Vadhavkar, Shweta; Cheu, Melissa; Wong, Kit; Omachi, Theodore A; Putnam, Wendy S; Quartino, Angelica L.
Afiliação
  • Zhu R; Genentech, Inc., South San Francisco, CA, USA.
  • Owen R; Genentech, Inc., South San Francisco, CA, USA. Electronic address: Owen.Ryan@gene.com.
  • Wilkins J; Occams Coöperatie U.A., Amstelveen, the Netherlands.
  • Schoemaker R; Occams Coöperatie U.A., Amstelveen, the Netherlands.
  • Tian X; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Gautier A; Novartis Pharma AG, Basel, Switzerland.
  • She G; Genentech, Inc., South San Francisco, CA, USA.
  • Vadhavkar S; Genentech, Inc., South San Francisco, CA, USA.
  • Cheu M; Genentech, Inc., South San Francisco, CA, USA.
  • Wong K; Genentech, Inc., South San Francisco, CA, USA.
  • Omachi TA; Genentech, Inc., South San Francisco, CA, USA.
  • Putnam WS; Genentech, Inc., South San Francisco, CA, USA.
  • Quartino AL; Genentech, Inc., South San Francisco, CA, USA.
Pulm Pharmacol Ther ; 71: 102080, 2021 12.
Article em En | MEDLINE | ID: mdl-34592476

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Sinusite / Pólipos Nasais Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Sinusite / Pólipos Nasais Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article